论文部分内容阅读
目的:探讨多索茶碱联合溴己新治疗慢性阻塞性肺疾病(慢阻肺)的临床效果。方法:将116例慢阻肺患者随机分为对照组与观察组各58例,对照组患者采用氨溴索治疗,观察组患者给予多索茶碱联合溴己新治疗,比较两组患者的临床治疗效果。结果:观察组患者的肺功能恢复时间、疾病复发率与临床总有效率均明显好于对照组,具有统计学意义(P<0.05)。结论:多索茶碱联合溴己新治疗慢阻肺患者可良好促进其肺功能恢复,提高临床治疗效果并降低疾病复发率。
Objective: To investigate the clinical efficacy of doxofylline combined with bromhexine in the treatment of chronic obstructive pulmonary disease (COPD). Methods: One hundred and sixty-six COPD patients were randomly divided into control group and observation group with 58 cases in each group. Patients in the control group were treated with ambroxol, while those in observation group were treated with doxofylline and bromhexine. treatment effect. Results: The pulmonary function recovery time, disease recurrence rate and total clinical effective rate in the observation group were significantly better than those in the control group, with statistical significance (P <0.05). Conclusion: Doxofylline combined with bromhexine in patients with COPD can promote the recovery of pulmonary function, improve the clinical effect and reduce the recurrence rate.